Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves lebrikizumab every-8-week maintenance dosing for moderate-to-severe atopic dermatitis
2
FDA expands TOFIDENCE (tocilizumab-bavi) indications to include CAR T-cell–induced CRS and pediatric COVID-19
3
New evidence backs pediatric flu vaccination efficacy as CDC drops it from childhood schedule
4
Distinguishing Functional Constipation From IBS-C and Embracing a Positive Diagnosis
5